Journal of Clinical Investigation
@jclinicalinvest
The JCI is a premiere venue for discoveries in basic & clinical biomedical science. Est. 1924- https://t.co/xG7OGiBetO
Bluesky: https://t.co/jMpYqQZxOk
ID:223605846
http://www.jci.org 06-12-2010 21:10:28
7,4K Tweets
52,1K Followers
3,4K Following
An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model: buff.ly/3w5zJJF
#Immunology
Up next in the ASCI Scientific Sessions:
Emily Wang
'Can we achieve health equity without ending mass incarceration?'
May 10, 1-2pm ET
Moderated by Susan Cheng, MD, MMSc, MPH Cedars-Sinai Academic Medicine
Free and open to all!
Register: buff.ly/4d8VsBk
#AuthorsTake : Prolonged transplant survival in preclinical models: buff.ly/49Q3pbq
Article: buff.ly/4a1M9Rc
Video: buff.ly/44admQ5
Leonardo V. Riella Mass General Kidneys
#Immunology
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia: buff.ly/49LBr0x
Richard Moriggl Vetmeduni
#Genetics #Hematology
CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4: buff.ly/3xWp2tn
Northwestern Feinberg School of Medicine
#Immunology #Metabolism
#AuthorsTake : A glycolysis/HIF1a axis in promoting G-MDSC activity and biofilm persistence during PJI is important: buff.ly/49OqWcU
Article: buff.ly/49OdA0m
Video: buff.ly/4d3x441
Tammy Kielian University of Nebraska Medical Center
#Immunology
Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice: buff.ly/3Qi8J0C
James Zimring UVA School of Medicine
#Immunology
A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis: buff.ly/3U6ffZ9
Michigan Medicine
#Development #Therapeutics
#Commentary :
Oncotherapy resistance explained by Darwinian and Lamarckian models: buff.ly/3Q5qjVk
Yogen Saunthararajah Cleveland Clinic
Related article: buff.ly/3w6wth7
#Commentary :
VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas: buff.ly/3JkPJuz
Boyi Gan, PhD MD Anderson Cancer Center
Related article: buff.ly/3JnBeGf
#Review : Capillary malformations: buff.ly/4aF1t6W
Elisa Boscolo University of Cincinnati
This review is part of JCI's latest #Review Series: buff.ly/49FhecX
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency: buff.ly/3w6wth7
Amit Verma Joshua Brody, MD Albert Einstein College of Medicine - Official Icahn School of Medicine at Mount Sinai NIH
#Oncology
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis: buff.ly/3JnBeGf
Qing Zhang UT Southwestern Medical Center
#Oncology
#ReviewSeries :
Infantile hemangioma: the common and enigmatic vascular tumor: buff.ly/3Jm2Uvg
Annegret Holm Joyce Bischoff
Boston Children's Harvard Medical School
JCI's latest #ReviewSeries : Vascular Malformations: buff.ly/49FhecX
Series editor Miikka Vikkula
This series will span hemangioma, hereditary hemorrhagic telangiectasia, lymphatic abnormalities, cerebral small vessel disease, capillary malformations, and more..
100th Anniversary #Viewpoints :
Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation: buff.ly/49xpuvz
Dana-Farber Masonic Cancer Center, University of Minnesota